Deal Type

Sensorion, a clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, has raised €50.5m (US$54.5m) through...

Nuveen Real Estate, a Teachers Insurance and Annuity Association of America (TIAA) company, has provided a €35m senior secured loan to Breakthrough Properties, a...

BioNTech, a next-generation immunotherapy company, and Autolus Therapeutics, a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, have announced a strategic collaboration aimed...

Curaleaf International, part of Toronto-listed Curaleaf Holdings, Europe's largest vertically integrated cannabis company, has acquired Can4Med, a pharmaceutical wholesaler specializing in cannabinoid medications in Poland. The acquisition...

Chanelle Pharma, Ireland’s largest indigenous manufacturer of generic pharmaceuticals for animal and human health, has been acquired by European PE investor, Exponent. Terms of the...

UK-headquartered biotech company, Silence Therapeutics, has placed an oversubscribed private placement of 5,714,286 of ADS with new and existing institutional and accredited investors at US$21.00...

Swiss multinational pharmaceutical company, Novartis has entered into an agreement to make a voluntary public takeover offer to acquire MorphoSys, a Germany-based, global biopharmaceutical...

Denmark-based major life science investor Novo Holdings, has entered into an agreement whereby it will acquire New York listed CDMO Catalent in an all-cash...

Global care provider, Orpea, has announced details on the reverse share split of all outstanding shares of the company. The Reverse Share Split will begin...

Micropos Medical, a developer of products for precision treatment of cancer, has launched a rights issue of 12,660,558 shares at SEK1.08 per share that,...